Can Celestica's Next-Generation HealthTech Portfolio Lift Its Shares?
Celestica Inc. is positioned to benefit from the expanding HealthTech market through its advanced manufacturing, engineering and supply chain solutions for medical devices. The company's portfolio spans imaging systems, surgical equipment, diabetes care and diagnostic products. With a Zacks Rank #1 (Strong Buy) rating, earnings estimates for 2026 and 2027 have increased significantly, though shares have underperformed the industry over the past year.